tsavy
@tsavy2
PhD student at Barts, tumour evo
ID: 3357465435
03-07-2015 21:34:25
538 Tweet
48 Followers
199 Following
📣We welcome NICE recommendation of olaparib for use on NHS England for #OvarianCancer maintenance treatment after previous treatment. The ICR and The Royal Marsden NHS Foundation Trust showed the effectiveness of olaparib for various indications in adults with #BRCA 1/2 mutations.
New content 🌟Perspective🌟 "Targeting therapy-persistent residual disease" by Xiaoxiao Sun, Lani Wu, Steven Altschuler & Aaron Hata UCSF School of Pharmacy @MGHCancerCenter 🔗nature.com/articles/s4301…
Join the discussion: Pervasive Cellular Plasticity intertwined with Darwinian Evolution in Cancer - does this need a new Evolutionary Theory? See our review just out in Trends in Cancer sciencedirect.com/science/articl…